These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17655599)

  • 1. Evaluating the impact of public health notification of suspected transfusion-transmissible hepatitis C virus infection and effectiveness of lookback and traceback investigations by Canadian Blood Services in British Columbia, Canada, August 2002 through February 2005.
    Whitlock M; Lord S; Buxton JA; Doyle P; Bigham M
    Transfusion; 2007 Aug; 47(8):1534-9. PubMed ID: 17655599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Canadian experience with targeted hepatitis C virus lookback.
    Goldman M; Patterson L; Long A
    Transfusion; 2006 May; 46(5):690-4. PubMed ID: 16686835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C lookback in Canada.
    Goldman M; Long A
    Vox Sang; 2000; 78 Suppl 2():249-52. PubMed ID: 10938962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992.
    Williams JL; Cagle HH; Christensen CJ; Fox-Leyva LK; McMahon BJ
    Transfusion; 2005 Jun; 45(6):1020-6. PubMed ID: 15935002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
    Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
    Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
    Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
    Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of transfusion-associated hepatitis C in a children's hospital.
    Luban NL; Colvin CA; Mohan P; Alter HJ
    Transfusion; 2007 Apr; 47(4):615-20. PubMed ID: 17381619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective assessment of donor blood screening for antibody to hepatitis C virus by first- and second-generation assays as a means of preventing posttransfusion hepatitis.
    Takano S; Nakamura K; Kawai S; Yokosuka O; Satomura Y; Omata M
    Hepatology; 1996 Apr; 23(4):708-12. PubMed ID: 8666321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia.
    Angelotta C; McKoy JM; Fisher MJ; Buffie CG; Barfi K; Ramsey G; Frohlich L; Bennett CL
    Vox Sang; 2007 Aug; 93(2):159-65. PubMed ID: 17683360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Face-to-face interviewing in predonation screening: lack of effect on detected human immunodeficiency virus and hepatitis C virus infections.
    O'Brien SF; Fan W; Ram SS; Goldman M; Nair RC; Chiavetta JA; Vamvakas EC
    Transfusion; 2006 Aug; 46(8):1380-7. PubMed ID: 16934075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood recipient notification for hepatitis C in Prince Edward Island.
    Van Til LD; Sweet LE
    CMAJ; 2000 Jan; 162(2):199-202. PubMed ID: 10674052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of transfusion-transmitted hepatitis C virus in a tertiary hospital in Nigeria.
    Imarengiaye CO; Enosolease ME; Iribhogbe PE; Ehigiegba AE
    Public Health; 2006 Mar; 120(3):274-8. PubMed ID: 16364383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of posttransfusion hepatitis by screening with second-generation anti-HCV antibody and clinical features of HCV infection.
    Nishikado T; Honda H; Kamamura M; Hibino S; Ito S
    Tokushima J Exp Med; 1996 Jun; 43(1-2):25-37. PubMed ID: 8885686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
    Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
    Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood safety & prevalence of transfussion transmissible viral infections among donors at the Red Cross Blood Bank in Gondar University Hospital.
    Diro E; Alemu S; G/Yohannes A
    Ethiop Med J; 2008 Jan; 46(1):7-13. PubMed ID: 18711984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Canadian hospital-based HIV/hepatitis C look-back notification program.
    Heddle N; Kelton JG; Smaill F; Foss K; Everson J; Janzen C; Walker C; Jones M; Hammons D
    CMAJ; 1997 Jul; 157(2):149-54. PubMed ID: 9238143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992.
    Cagle HH; Jacob J; Homan CE; Williams JL; Christensen CJ; McMahon BJ
    Arch Pediatr Adolesc Med; 2007 Feb; 161(2):125-30. PubMed ID: 17283296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.